{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

45Drives' 45Studio Enters Beta Testing of New Remote On-Premise Collaboration Platform for Video Professionals

November 4, 2025SYDNEY, NOVA SCOTIA and WILMINGTON, NC - November 4, 2025 (NEWMEDIAWIRE) - Open-source storage leader 45Drives today announced the beta launch of a remote collaboration platform using on-premise storage for video professionals, developed by its creative technology division, 45Studio. Currently in active beta testing, this new platform, a powerful, self-hosted alternative to Frame.


Hybrid Power Solutions Announces Distribution Agreement With Dragonfly Energy Holdings Corp.

November 4, 2025Strategic Partnership to Expand Distribution of Hybrid’s Advanced Battery Energy Storage Systems TORONTO, ONTARIO - November 4, 2025 (NEWMEDIAWIRE) - Hybrid Power Solutions Inc. (CSE: HPSS) (OTC: HPSIF) (FSE: E092) ("Hybrid" or the "Company"), a Canadian manufacturer of advanced battery energy storage and portable power systems, is excited to announce a new distribution agreement (“Agreement”) with Dragonfly Energy Holdings Corp.


SuperCloud International Opens Pre-Orders for the Liberty Stealth Phone, the World's Most Private Smartphone

November 4, 2025Breakthrough Device Built in the USA Offers Military-Grade Privacy Protection and Complete Digital Independence FORT LAUDERDALE, FL - November 4, 2025 (NEWMEDIAWIRE) - SuperCloud International, Inc. , a leading multimedia and technology company advancing privacy-first communication and entertainment platforms, today announced that pre-orders are now open for its Liberty Stealth Phone, the world’s most private smartphone built entirely in the United States.


Finalists Named in Global Health Technology Competition to Advance Heart and Brain Health

November 4, 2025DALLAS - November 4, 2025 (NEWMEDIAWIRE) - Health care innovation often outpaces adoption - especially for people with heart disease and stroke, the world’s leading causes of death. To help bridge this gap, the American Heart Association®, a relentless force changing the future of health for everyone everywhere, has named five finalists in its 8th annual Health Tech Competition, hosted by the Center for Health Technology & Innovation.


tZERO and Voatz Partner to Bring Blockchain Transparency to Corporate Proxy Voting

November 4, 2025 A New Standard for Shareholder Participation - Secure, Verified, and Recorded On-Chain NEW YORK, NY and BOSTON, MA - November 4, 2025 (NEWMEDIAWIRE) - tZERO Group, Inc. , a leader in blockchain and tokenization for capital markets, and Voatz, a pioneer in secure mobile voting, today announced a strategic collaboration to deliver blockchain‑backed proxy voting.


Critical Infrastructure Technologies Provides Nexus Production Update

November 4, 2025VANCOUVER, BC - November 4, 2025 (NEWMEDIAWIRE) - Critical Infrastructure Technologies Ltd. (CSE: CTTT) (OTC: CITLF) (FRA: X9V) (“CiTech” or the “Company”), a leading developer of autonomous, high-capacity mobile communications and security platforms, is pleased to provide an update on the production and delivery schedule for its Nexus platform series, with multiple units entering final assembly and deployment phases in key international markets.


US Nuclear Corp Replaces Audit Firm With Simon & Edward LLP Effective Immediately, While Reducing 3rd Quarter Debt by Close to $800K

November 4, 2025LOS ANGELES, CA - November 4, 2025 (NEWMEDIAWIRE) - US Nuclear Corp (OTC: UCLE), is pleased to announce that the Company has Replaced the Audit Firm of Fruci & Associates II, PLLC, with Simon & Edwards LLP, Effective October 29, 2025. “We are actively looking to add an experienced VP of Sales, along with Sales Reps and Distributors to help service our growing customer list,” said Nikki Truax, Director of Operations of Overhoff Technology, our main Manufacturing and Sales Operation.


Three Health Tech Innovators Recognized for Digital Solutions to Transform Cardiovascular Care

November 4, 2025DALLAS - November 4, 2025 (NEWMEDIAWIRE) - As digital health technologies gain momentum,[1] research is finding that more people are open to artificial intelligence (AI) supported health interventions when those are backed by clinical expertise and rooted in evidence-based guidelines. [2] To harness this opportunity, the American Heart Association, a relentless force changing the future of health for everyone everywhere, launched its inaugural CarePlan Challenge this year to drive innovation and expand access to guideline-based cardiovascular care.


TTL AG invites Shareholders to Extraordinary Annual General Meeting on December 9, 2025

November 3, 2025MUNICH - November 3, 2025 (NEWMEDIAWIRE) - TTL Beteiligungs- und Grundbesitz-AG ("TTL AG") invites its shareholders to an extraordinary Annual General Meeting on December 9, 2025. The invitation to the Annual General Meeting was published in the Federal Gazette on October 31, 2025, in accordance with the statutory provisions.


Thomas Meier Becomes New CEO of Medios AG

November 3, 2025BERLIN - November 3, 2025 (NEWMEDIAWIRE) - The Supervisory Board of Medios AG has appointed Thomas Meier as a member of the Executive Board with effect from February 1, 2026, and designated him the new Chief Executive Officer (CEO) of the Company. He succeeds Matthias Gaertner, who will remain in office until December 31, 2025.


Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar

November 3, 2025 Objective responses and promising anti-tumor activity observed in several patients across multiple cohorts in the ongoing Phase I/IIa clinical trial Data reinforces the therapeutic potential and safety profile of HDP-101 in relapsed or refractory multiple myeloma. R&D Webinar to be hosted on 11 November 2025 at 05:00 pm CET (08:00 am PST) LADENBURG, Germany - November 3, 2025 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage developer of innovative Antibody Drug Conjugates (ADCs), today announced the presentation of new clinical data from its ongoing Phase I/IIa clinical study evaluating its lead Amanitin-based ADC candidate, HDP-101 (INN: pamlectabart tismanitin), at the 16th Annual World ADC Congress, taking place in San Diego, California, from 3 to 6 November 2025.